Cargando…

The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis

The purpose of this meta-analysis was aimed to evaluate the association of tumor protein p53 (TP53) gene codon 72 polymorphism with leukemia susceptibility. We searched PubMed to identify relevant studies, and 16 case-control studies from 14 published articles were identified as eligible studies, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Xiao-Lan, Li, Sheng, Meng, Xiang-Yu, Geng, Peiliang, Gao, Qing-Ping, Ao, Xu-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635761/ https://www.ncbi.nlm.nih.gov/pubmed/26402821 http://dx.doi.org/10.1097/MD.0000000000001588

Ejemplares similares

Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis
por: Ruan, Xiao-Lan, et al.
Publicado: (2015)

Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies
por: Weber, Emmanuelle, et al.
Publicado: (2017)

Red and Processed Meat Consumption Increases Risk for Non-Hodgkin Lymphoma: A PRISMA-Compliant Meta-Analysis of Observational Studies
por: Yang, Li, et al.
Publicado: (2015)

Cutaneous presentation preceding acute monocytic leukemia: A CARE-compliant article
por: Jin, Xianhua, et al.
Publicado: (2017)

Association of TP53 gene codon 72 polymorphism with endometriosis risk in Isfahan
por: Nikbakht Dastjerdi, Mehdi, et al.
Publicado: (2013)

The incidence and prognostic effect of Fms-like tyrosine kinase 3 gene internal tandem and nucleolar phosphoprotein 1 genes in acute myeloid leukaemia: A PRISMA-compliant systematic review and meta-analysis
por: Liu, Heping, et al.
Publicado: (2020)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study
por: Maral, Senem, et al.
Publicado: (2015)

Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article
por: Gao, Yayue, et al.
Publicado: (2017)

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
por: Toyama, Tatsuya, et al.
Publicado: (2007)

TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells
por: Altilia, Serena, et al.
Publicado: (2012)

Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis
por: Gonçalves, Meire Luzia, et al.
Publicado: (2014)

The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients
por: BABAEI, Farhad, et al.
Publicado: (2014)

Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes
por: Słomiński, Bartosz, et al.
Publicado: (2021)

An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article
por: Wu, Bin, et al.
Publicado: (2017)

Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls
por: Zhuo, Wenlei, et al.
Publicado: (2009)

Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study
por: Schiefer, Ana-Iris, et al.
Publicado: (2015)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
por: Hori, Yasuki, et al.
Publicado: (2015)

TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma
por: Mascelli, Samantha, et al.
Publicado: (2016)

Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer
por: Lin, Ying-Mei, et al.
Publicado: (2018)

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study
por: Lung, For-Wey, et al.
Publicado: (2009)

Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis
por: Zeng, Xian-Tao, et al.
Publicado: (2014)

Increased Risk of Cutaneous Melanoma Associated with p53 Arg72Pro Polymorphism
por: Geng, Peiliang, et al.
Publicado: (2015)

Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women
por: Mostaid, Md Shaki, et al.
Publicado: (2021)

TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses
por: Lin, Hung-Yu, et al.
Publicado: (2008)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders
por: Li, Huangkai, et al.
Publicado: (2023)

Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia: A case-control study
por: Zou, Yunding, et al.
Publicado: (2017)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
por: Moe, Svein Erik, et al.
Publicado: (2023)

P53 codon 11, 72, and 248 gene polymorphisms in endometriosis
por: Hsieh, Yao-Yuan, et al.
Publicado: (2006)

The establishment and evaluation of a new model for the prediction of Children B-ALL based on TARGET: A SQUIRE-compliant study
por: Gao, Xiangyu, et al.
Publicado: (2020)

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer
por: Costa, Sandra, et al.
Publicado: (2008)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma
por: Fang, Xia, et al.
Publicado: (2017)

Transformation from acute promyelocytic leukemia to acute myeloid leukemia with a CEBPA double mutation: A case report and review of the literature
por: Sun, Ye, et al.
Publicado: (2021)

“p53 Polymorphism at Codon 72 and Breast Cancer” - Letter
por: Afzaljavan, Fahimeh, et al.
Publicado: (2017)

AML, ALL, and CML classification and diagnosis based on bone marrow cell morphology combined with convolutional neural network: A STARD compliant diagnosis research
por: Huang, Furong, et al.
Publicado: (2020)

An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant)
por: Koga, Tomohiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s6imd9l4dj8qvqcdcane75nmet